Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 11, 2021SHILAP Revista de lepidopterologíaOpen Access

Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLiyun LuoGuangzhou Medical University Cancer HospitalZZZhijie ZhangBeijing University of Chinese MedicineNQNi QiuGuangzhou Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Luo et al. (2021) studied this question.

synapsesocial.com/papers/69db2dc97a67537a8ba3d161https://doi.org/10.1038/s41467-021-23052-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin2013 · 101 citations
  2. 2Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC52011 · 256 citations
  3. 3The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells2015 · 25 citations
  4. 4ErbB-Dependent Signaling as a Determinant of Trastuzumab Resistance2007 · 19 citations
  5. 5Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications2012 · 390 citations